- Home
- LEXX vs CMBM Comparison
LEXX vs CMBM Comparison
Compare LEXX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- CMBM
- Stock Information
- Founded
- LEXX 2004
- CMBM 2011
- Country
- LEXX Canada
- CMBM United States
- Employees
- LEXX N/A
- CMBM N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- LEXX Health Care
- CMBM Technology
- Exchange
- LEXX Nasdaq
- CMBM Nasdaq
- Market Cap
- LEXX 16.5M
- CMBM 18.6M
- IPO Year
- LEXX N/A
- CMBM 2019
- Fundamental
- Price
- LEXX $1.30
- CMBM $0.72
- Analyst Decision
- LEXX Strong Buy
- CMBM Buy
- Analyst Count
- LEXX 1
- CMBM 1
- Target Price
- LEXX $4.00
- CMBM $3.00
- AVG Volume (30 Days)
- LEXX 193.3K
- CMBM 173.4K
- Earning Date
- LEXX 07-14-2025
- CMBM 11-06-2025
- Dividend Yield
- LEXX N/A
- CMBM N/A
- EPS Growth
- LEXX N/A
- CMBM N/A
- EPS
- LEXX N/A
- CMBM N/A
- Revenue
- LEXX $615,923.00
- CMBM $172,215,000.00
- Revenue This Year
- LEXX $46.98
- CMBM N/A
- Revenue Next Year
- LEXX $17.26
- CMBM $17.73
- P/E Ratio
- LEXX N/A
- CMBM N/A
- Revenue Growth
- LEXX 49.85
- CMBM N/A
- 52 Week Low
- LEXX $0.77
- CMBM $0.23
- 52 Week High
- LEXX $3.47
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- LEXX 76.03
- CMBM 49.46
- Support Level
- LEXX $0.98
- CMBM $0.62
- Resistance Level
- LEXX $1.34
- CMBM $0.77
- Average True Range (ATR)
- LEXX 0.09
- CMBM 0.06
- MACD
- LEXX 0.04
- CMBM 0.00
- Stochastic Oscillator
- LEXX 91.72
- CMBM 44.10
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.